BWS
MRNA icon

Buck Wealth Strategies’s Moderna MRNA Stock Holding History

Buck Wealth Strategies’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$630 Buy
+9
New +$466 ﹤0.01% 983
2023
Q4 		– Sell
-10
Closed -$1.03K – 250
2023
Q3 		$1.03K Hold
10
– – ﹤0.01% 333
2023
Q2 		$1.22K Hold
10
– – ﹤0.01% 251
2023
Q1 		$1.54K Buy
+10
New +$1.65K ﹤0.01% 187

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Buck Wealth Strategies's MRNA Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in Moderna (MRNA) in Q2 2026: 9 shares worth $630. The stake represents ﹤0.01% of the portfolio and ranks #983 among its holdings. This is a return to the name: Buck Wealth Strategies previously reported a position in MRNA as recently as Q3 2023.

Buck Wealth Strategies first reported a position in MRNA in Q1 2023 and has held it in 4 quarters since. The position peaked at $1.54K in Q1 2023. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Buck Wealth Strategies held 9 shares of Moderna worth $630 as of Q2 2026.
  • Moderna was a new Buck Wealth Strategies position in Q2 2026.
  • Moderna made up ﹤0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #983 holding.
  • Buck Wealth Strategies first reported a position in Moderna in Q1 2023 and has held it in 4 quarters since.
  • Buck Wealth Strategies's Moderna position peaked at $1.54K in Q1 2023.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.